It is thought that carrying out medical research for developing nations is the responsibility of pharmaceutical corporations. However, some argue that gaining profit will be their main purpose. From my perspective, companies tend to make considerable fortunes in the situation of diseases worldwide, which I would elaborate on in the following essay.
First of all, it’s undeniable that apart from those poverty-stricken countries, every nation has been encountering the problems of a wide variety of illnesses. One particularly salient example of this can be seen in the outbreak of coronavirus pandemic in the current two years. A number of companies getting involved in the invention of vaccines aim to assist all countries around the world to overcome the tough challenges. Undoubtedly, the disease creates great opportunities for them to boost international sales.
Even more crucial, though, is that the majority of the corporations are profit-oriented, creating maximum profits would be their first priority. Poor countries may have insufficient capital and market, simply targeting customers from there would inevitably limit their profits, which is extremely opposed to their original mission. When their revenue couldn’t meet their costs, it may lead to bankruptcy, having a negative impact on the economy.
Admittedly, some critics may endorse that pharmaceutical companies in advanced countries should have corporate responsibility to help impoverished economies. Inventing drugs requires long-term inputs, including talented researchers and mass funds, which are not affordable for poor countries. Therefore, they are expected to engage in absorbing those costs, and sell their new-invented drugs to needful nations all over the world.
In conclusion, I remain convinced that pharmaceutical corporations should focus on developing their business. Not only should every nation come up with their own solutions to settle the problems, but those medical companies ought to target countries all over the globe to pursue the largest profits.
It is
thought
that carrying out medical research for developing
nations
is the responsibility of pharmaceutical corporations.
However
,
some
argue that gaining
profit
will be their main purpose. From my perspective,
companies
tend to
make
considerable fortunes in the situation of diseases worldwide, which I would elaborate on in the following essay.
First of all
, it’s undeniable that apart from those poverty-stricken
countries
, every
nation
has been encountering the problems of a wide variety of illnesses. One
particularly
salient example of this can be
seen
in the outbreak of coronavirus pandemic in the
current
two years. A number of
companies
getting involved in the invention of vaccines aim to assist all
countries
around the world to overcome the tough challenges.
Undoubtedly
, the disease creates great opportunities for them to boost international sales.
Even more crucial, though, is that the majority of the corporations are profit-oriented, creating maximum
profits
would be their
first
priority. Poor
countries
may have insufficient capital and market,
simply
targeting customers from there would
inevitably
limit their
profits
, which is
extremely
opposed to their original mission. When their revenue couldn’t
meet
their costs, it may lead to bankruptcy, having a
negative
impact on the economy.
Admittedly
,
some
critics may endorse that pharmaceutical
companies
in advanced
countries
should have corporate responsibility to
help
impoverished economies. Inventing drugs requires long-term inputs, including talented researchers and mass funds, which are not affordable for poor
countries
.
Therefore
, they are
expected
to engage in absorbing those costs, and sell their new-invented drugs to needful
nations
all over the world.
In conclusion
, I remain convinced that pharmaceutical corporations should focus on developing their business. Not
only
should every
nation
come
up with their
own
solutions to settle the problems,
but
those medical
companies
ought to target
countries
all over the globe to pursue the largest
profits
.